Skip to content

Gracell Biotechnologies Inc.

CIK 0001826492

← back to feed
Revenue (TTM)
—
Q2 Jun 2023
Net Income (TTM)
—
Q2 Jun 2023
EPS Diluted (TTM)
−¥0.26
−18.2% YoY Q2 Jun 2023
Gross Margin
—
Q2 Jun 2023
Operating Margin
—
Q2 Jun 2023
Net Margin
—
Q2 Jun 2023
Free Cash Flow (TTM)
−¥76.99M
Q2 Jun 2023
Cash
¥163.34M
Q2 Jun 2023
Total Debt
¥19.72M
Q2 Jun 2023
Shares Outstanding
338.5M sh
Q2 Jun 2023

EPS (Diluted)

Cash Flow

Balance Sheet

Cash vs Debt

Recent filings